A business leader in the Biotechnology/Pharmaceutical Industry, Paul has a proven track record of performance and experience leading people and business in biotechnology and rare disease in both Canada and the United States. His experience includes building and growing businesses with such companies as GlaxoSmithKline, Astra Zeneca, Biogen and of recent, Jazz Pharmaceuticals.
He is an active member of the board with; The Biomedical Discovery and Commercialization Program at McMaster University Department of Biochemistry and Biomedical Sciences and Biotech Canada, where he is as board chair, and is a member of the Life Sciences Advisory Consortium City of Mississauga. He also served as member of the board with the Lymphoma and Leukemia Society of Canada. Paul also contributes as faculty for the Marketing Pharmaceuticals in Canada Program, the National Pharmaceutical Congress and the Science to Business Academy.
Paul has Bachelor’s degree in Biology, Genetics, from the University of Toronto and a graduate of the Institute of Corporate Directors program at the Rotman School of Management, University of Toronto.